Compare GEVO & UROY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GEVO | UROY |
|---|---|---|
| Founded | 2005 | 2017 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Major Chemicals | |
| Sector | Industrials | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 470.1M | 513.2M |
| IPO Year | 2011 | N/A |
| Metric | GEVO | UROY |
|---|---|---|
| Price | $2.28 | $3.75 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $8.13 | $4.50 |
| AVG Volume (30 Days) | ★ 3.1M | 2.0M |
| Earning Date | 11-10-2025 | 12-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $120,932,000.00 | $35,266,447.00 |
| Revenue This Year | $927.85 | $195.97 |
| Revenue Next Year | $12.01 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 675.75 | 14.29 |
| 52 Week Low | $0.92 | $1.43 |
| 52 Week High | $2.98 | $5.37 |
| Indicator | GEVO | UROY |
|---|---|---|
| Relative Strength Index (RSI) | 55.60 | 46.11 |
| Support Level | $1.83 | $3.63 |
| Resistance Level | $2.42 | $4.07 |
| Average True Range (ATR) | 0.12 | 0.21 |
| MACD | 0.03 | 0.03 |
| Stochastic Oscillator | 71.19 | 58.24 |
Gevo Inc is a renewable chemicals and biofuels company engaged in the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks. The operating segments are the Gevo segment, GevoFuels segment, and the GevoRNG segment. By its segments, it is involved in research and development activities related to the future production of SAF, commercial opportunities for other renewable hydrocarbon products and isobutanol, including the development of its biocatalysts, and the produces-pipeline quality methane gas captured from dairy cow manure. The company derives maximum revenue from the GevoRNG segment.
Uranium Royalty Corp is focused on gaining exposure to uranium prices by making investments in uranium interests, including royalties, streams, debt and equity investments in uranium companies, and through holdings of physical uranium. The company operates in a single segment that is acquiring and assembling a portfolio of royalties, investing in companies with exposure to uranium and physical uranium. The Company also engages in the purchase and sale of physical uranium.